期刊文献+

家族性乙型肝炎病毒基因型分布与临床转归关系的研究 被引量:1

Familial Hepatits B Virus Genotypes and Clinical Prognosis
原文传递
导出
摘要 目的调查家族性乙型肝炎病毒(HBV)基因型的分布,分析基因型与临床转归的相关性。方法以136例家族性乙型肝炎患者为研究对象,用S基因巢式聚合酶链反应-限制片段长度多态性(ntPCR-RFLP)基因型分型方法测定HBV基因型。结果家族性乙型肝炎患者HBV基因分型为C型124例、B+C混合型7例、B型3例、未确定型2例;C型在原发性肝癌(HCC)中占有绝对优势(100.0%),其次为肝硬化(LC,96.0%),慢性乙型肝炎(CHB,95.3%),慢性乙型肝炎携带者(ASC,66.7%),与C型相比基因型B型、B+C混合型仅在ASC和CHB中存在,其所占比例分别为9.5%、23.8%和1.2%、2.3%。山西地区家族性乙型肝炎患者中未发现A~H中其他基因型的存在。结论山西地区家族性HBV基因型主要以C型为主,有少量B型和B+C混合型;C型感染所致的肝病预后差。 OBJECTIVE To investigate the distribution of familial hepatitis B virus (HBV) genotypes and analyze the relationship between genotypes and clinical outcome. METHODS A total of 136 cases of familial hepatitis B were involved in this study, including 25 cases of asymptomatiee HBV carriers (ASC), 85 cases of chronic hepatits 13 (CHB), 24 cases of liver cirrhosis (LC) and 4 cases of hepatocellular carcinoma (HCC). Nested polymerase chain reaction-restriction fragment length polymorphism (ntPCR-RFLP)was used to identify the genotypes of HBV. RESULTS There were 124 cases with hepatitis genotype C, 7 cases with genotypes B+ C mixed,3 cases with genotype B and 2 cases that did not conformed to be any of genotypes from A to H. Genotype C in the HCC was predominant genotype (100%), next in the LC(96%), CHB (95. 3%) and ASC(66. 7%). Compared with genotype C, genotypes B and B--C only existed in ASC and CHB, the proportion was 9.5% vs 23.8% and 1. 2% vs 2. 3%, respectively. There were no other HBV genotypes from A to H seen in familial hepatitis B in Shanxi province. CONCLUSIONS ttBV genotype C is the major one in familial hepatitis B in Shanxi. There are a few genotypes B and B+C existed. Genotype C induces a relatively bad prognosis.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第18期2394-2396,共3页 Chinese Journal of Nosocomiology
关键词 家族性乙型肝炎 乙型肝炎病毒 基因型 ntPCR-RFLP Familial hepatitis B HBV Genotype ntPCR-RFLP
  • 相关文献

参考文献6

二级参考文献24

  • 1宋淑静,何忠平,庄辉,闫杰,董庆鸣.中国北方5城市慢性乙型肝炎患者的基因分型[J].中国公共卫生,2004,20(2):166-167. 被引量:40
  • 2宋淑静,庄辉,闫杰,魏红山,何忠平,宋川,董庆鸣,肖元朴.拉米夫定早期疗效与乙型肝炎病毒基因型的关系[J].中华预防医学杂志,2005,39(3):203-205. 被引量:10
  • 3庄辉.慢性乙型肝炎病毒感染及其防治[J].中华肝脏病杂志,2005,13(5):324-325. 被引量:35
  • 4黄增相,张惠泉,杨柳明,徐克诚.乙肝病毒携带者肝脏病理检查的临床价值[J].实用医学杂志,2005,21(11):1179-1180. 被引量:13
  • 5Zollner B, Petersen J, Schroter M, et al. 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet, 2001,357: 934-935.
  • 6Norder H, Courouce AM, Magnius LO, et al. Complete genomes,phylogenetic relatedness, and structural proteins of the hepatitis B virus, four of which represent two new genotypes.Virology, 1994, 198: 489-503.
  • 7Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol, 2000, 81: 67-74.
  • 8Stuyver L J, Locarnini SA, Lok A, et al. Nomenclature for antiviralresistant human hepatitis B virus mutations in the polymerase region.Hepatology, 2001, 33:751-757.
  • 9Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology, 1996, 24:711-713.
  • 10Usuda S, Okamoto H, Iwanari H, et a1. Serological detection in hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.J Virol Methods, 1999, 80: 97-112.

共引文献14063

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部